Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Iveric Bio Inc
(NQ:
ISEE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 10, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iveric Bio Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 01, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
June 10, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022
June 08, 2022
Upgrades
Via
Benzinga
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Iveric Bio to Present at the UBS Global Healthcare Conference 2022
May 17, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference
May 16, 2022
From
IVERIC bio, Inc.
Via
Business Wire
IVERIC bio: Q1 Earnings Insights
May 04, 2022
IVERIC bio (NASDAQ:ISEE) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IVERIC bio reported in-line EPS of...
Via
Benzinga
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
May 04, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Iveric Bio Announces Presentation of Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
May 04, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2022
From
IVERIC Bio, Inc.
Via
Business Wire
IVERIC bio Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
IVERIC bio (NASDAQ:ISEE) will host a conference call at 08:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend IVERIC bio (ISEE) Conference Call Follow this link to access the...
Via
Benzinga
Iveric Bio to Report First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 4, 2022
April 27, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Iveric Bio to Participate in the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference
April 26, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2022
From
Iveric Bio
Via
Business Wire
These Are Ten Small Cap Stocks With Strong Buy Recommendations
March 27, 2022
One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks...
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022
March 22, 2022
Upgrades For Procter & Gamble Co (NYSE:PG), Truist Securities upgraded the previous rating of Hold to Buy. For the second quarter, Procter & Gamble had an EPS of $1.66,...
Via
Benzinga
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks
March 09, 2022
Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the approval of many...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,...
Via
Benzinga
Iveric Bio to Present at the Cowen 42nd Annual Health Care Conference
February 28, 2022
From
Iveric Bio
Via
Business Wire
Iveric Bio Reports Fourth Quarter and Full Year 2021 Operational Highlights and Financial Results
February 24, 2022
From
IVERIC bio, Inc.
Via
Business Wire
Earnings Outlook For IVERIC bio
February 23, 2022
IVERIC bio (NASDAQ:ISEE) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Iveric Bio to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022
February 17, 2022
From
IVERIC bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
February 11, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI...
Via
Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
Iveric Bio Announces Foveal Anatomy Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura® in Patients with Geographic Atrophy
February 11, 2022
From
IVERIC bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
February 10, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI)...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022
February 07, 2022
Upgrades For Enova International Inc (NYSE:ENVA), Maxim Group upgraded the previous rating of Hold to Buy. For the fourth quarter, Enova International had an EPS of $1.61,...
Via
Benzinga
Futures Tread Water Amid Peripheral Bond Rout As Key CPI Print Looms
February 07, 2022
U.S. index futures swung around in a volatile, illiquid overnight session, and at last check were flat despite traders' concerns about growing fireworks in the European bond market where Italian and...
Via
Talk Markets
Iveric Bio Announces New Post-Hoc Analyses of Zimura® from GATHER1 Clinical Trial to Be Presented at Angiogenesis, Exudation, and Degeneration 2022
February 07, 2022
From
IVERIC Bio, Inc.
Via
Business Wire
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2022
From
IVERIC bio, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.